132 related articles for article (PubMed ID: 11536259)
21. Early prediction of severe twin-to-twin transfusion syndrome.
Sebire NJ; Souka A; Skentou H; Geerts L; Nicolaides KH
Hum Reprod; 2000 Sep; 15(9):2008-10. PubMed ID: 10967005
[TBL] [Abstract][Full Text] [Related]
22. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
23. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K; Liao AW; Skentou H; Cicero S; Nicolaides KH
Prenat Diagn; 2000 Jun; 20(6):495-9. PubMed ID: 10861716
[TBL] [Abstract][Full Text] [Related]
24. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K; Bindra R; Nix AB; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):142-8. PubMed ID: 12905507
[TBL] [Abstract][Full Text] [Related]
25. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
[TBL] [Abstract][Full Text] [Related]
26. Nuchal translucency in twins according to mode of assisted conception and chorionicity.
Maymon R; Cuckle H; Svirsky R; Sheena L; Melcer Y; Rozen H; Ben-Ami I
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):38-43. PubMed ID: 24339187
[TBL] [Abstract][Full Text] [Related]
27. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
[TBL] [Abstract][Full Text] [Related]
28. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
29. The effect of fetal neck position on nuchal fold thickness.
Olson G; Saade GR; Zlatnik M; Dildy GA; Belfort M
Am J Obstet Gynecol; 2000 Oct; 183(4):995-7. PubMed ID: 11035352
[TBL] [Abstract][Full Text] [Related]
30. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
[TBL] [Abstract][Full Text] [Related]
31. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
Brady AF; Pandya PP; Yuksel B; Greenough A; Patton MA; Nicolaides KH
J Med Genet; 1998 Mar; 35(3):222-4. PubMed ID: 9541107
[TBL] [Abstract][Full Text] [Related]
32. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
[TBL] [Abstract][Full Text] [Related]
33. Relationship between fetal nuchal translucency and crown-rump length in an Asian population.
Jou HJ; Wu SC; Li TC; Hsu HC; Tzeng CY; Hsieh FJ
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):111-4. PubMed ID: 11251917
[TBL] [Abstract][Full Text] [Related]
34. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
Whitlow BJ; Economides DL
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
[TBL] [Abstract][Full Text] [Related]
35. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
36. [Nuchal translucency measurement--an effective method for early recognition of fetal disease?].
Böhmer S; Lampe S; Blümel P
Z Geburtshilfe Neonatol; 2003; 207(3):79-83. PubMed ID: 12891465
[TBL] [Abstract][Full Text] [Related]
37. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
38. Association between fetal nuchal translucency thickness in first trimester and subsequent gestational hypertension and preeclampsia.
Tsai MS; Lee FK; Cheng CC; Hwa KY; Cheong ML; She BQ
Prenat Diagn; 2002 Sep; 22(9):747-51. PubMed ID: 12224064
[TBL] [Abstract][Full Text] [Related]
39. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
40. Prenatal course and pregnancy outcome of fetuses with a transient nuchal translucency.
Fukada Y; Amemiya A; Kohno K; Sunami R; Kobayashi Y; Hoshi K
Int J Gynaecol Obstet; 2002 Dec; 79(3):225-8. PubMed ID: 12445987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
